메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Anouk Benseler (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada) Allan Covens
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.35 No.2
발행연도
2024.3
수록면
1 - 3 (3page)
DOI
https://doi.org/10.3802/jgo.2024.35.e49

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Cer vical cancer is the fourth most common cancer in women [1]. While we hope globalhuman papillomavirus vaccination efforts will change this reality, as a result of screeningprograms 42% of women in North America present with localized disease [2]. Radicalhysterectomy has been recommended for most patients, presenting with stage IA2 to 4 cmIB3 cancers [3]. Overall sur vival is excellent, however there are significant adverse effectsassociated with parametrial and vaginal resection [4]. We congratulate Plante et al. on completing this randomized non-inferiority trial of 700patients with stage 1A2 and 1B1 cer vical cancer comparing simple hysterectomy and pelvicnode dissection to radical hysterectomy and pelvic node dissection (recently published inthe New England Journal of Medicine) [5]. The primar y endpoint was designed to detect non-inferiority of pelvic-relapse free sur vival at 3 years, with secondar y outcomes including overallsur vival, parametrial involvement, quality of life and treatment-related toxicity. The 3-yearpelvic-recurrence rate was 2.5% in the simple hysterectomy group and 2.2% in the radicalhysterectomy group per intention to treat analysis (2.8% and 2.3% per protocol analysis) andthe upper 95% confidence limit did not meet the pre-defined threshold of inferiority. The3-year extra pelvic relapse-free sur vival and overall sur vival were 98.1% vs. 99.7% and 99.1%vs. 99.4%, respectively. Surgical margins were similar (2.4% SH vs. 2.7% RH). Patient reported outcomes of sexual health were measured by the Female Sexual FunctionIndex and the Female Sexual Distress Scale-Revised, and bowel, bladder and non-sexualvaginal symptoms were measured by EORTC QLQ-C30 with QLQ-CX24. Simple hysterectomywas associated with decreased pain experience and favorable sexual health. Patients whounder went simple hysterectomy reported less sexual worr ying and increased sexual enjoymentat 3 months, less sexual pain and improved sexual lubrication for the first 12 months, andimproved sexual vaginal functioning for the first 24 months. Overall better body image andincreased sexual activity was reported for up to 36 months. Decreased urinar y retentionand incontinence also favored simple hysterectomy (0.6% vs. 9.9% and 4.7% vs. 11%,respectively). These findings of decreased sexual health and increased bladder symptoms inpatients undergoing radical hysterectomy are consistent with the literature [6-9]. The ConCer v trial prospectively evaluated patients with cer vical cancer up to 2 cm, treatedwith conization or simple hysterectomy, and concluded conser vative surger y may be offeredbased on a cumulative recurrence of 3.5% over a median follow up of 36.3 months [10].A systematic review of the literature including 2,662 women demonstrated no significantassociation between mortality and simple vs. radical hysterectomy in patients withmicroscopic disease, and the recent SCCAN retrospective trial of 1,257 patients comparingtype B, C1 and C2 radical hysterectomy techniques found no sur vival difference for tumors upto 2 cm with increased radicality of surger y [11,12]. What can we conclude from all this? The evidence from these studies is congruent; nonradical surger y for small cer vical cancers is safe, not associated with increased relapse rates,and improves quality of life, measured through patient reported outcomes. Rarely do wefind a therapy, that relative to standard of care, is as effective yet less complex, less costly andbetter tolerated by patients. While it is unlikely this study will be replicated, these findingsstimulate additional questions. With no reason to suspect other wise, will the 5-year overallsur vival be consistent with these 3-year findings? Given that the majority of patients inthe ConCer v trial (96%) and the SHAPE trial (75%) under went minimally invasive surger yfor their hysterectomy, what is the optimal surgical approach for these patients [10,13]?Can sentinel node biopsy replace full pelvic lymphadenectomy for cer vical cancer staging?(Hopefully answered in the SENTICOL3 study [14].) What is the optimal vaginal/tumour freeresection margin? In patients wishing for fertility preser vation can an analogous evidencebase be used to support treatment with cone biopsy or simple trachelectomy and pelviclymph node assessment (as proposed in the ConCer v trial [10])?While we eagerly await the GOG 278 trial results to provide further prospective evidence ofquality of life measures and relapse-free sur vival in women with early cer vical cancer treatedwith simple hysterectomy, it would seem obvious to most clinicians that patients meetingthe inclusion criteria of the SHAPE study, can (and should) now be treated with simplehysterectomy rather than radical hysterectomy.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청
참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0